X0607 3 2026-07-16 0 0001980845 enGene Therapeutics Inc. ENGN 0002014509 Chinoporos Constantine true C/O 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 QUEBEC, CANADA true Interim Chief Business Officer Stock Option (Right to Buy) 1.75 2036-06-16 Common Shares 75000 D This option vests monthly in substantially equal amounts for 48 months, commencing June 16, 2026, subject to the Reporting Person's continued service. Exhibit 24 - Power of Attorney /s/ Kathleen P. Richton, as attorney-in-fact for the Reporting Person 2026-07-22